Nitazoxanide anthelmintic activity against the enteral and parenteral phases of trichinellosis in experimentally infected rats

Experimental Parasitology

Volumn 170, Issue , 2016, Pages 28-35

  Ashour, Dalia S ^a   Abou Rayia, Dina M ^a   Saad, Abeer E ^a   El Bakary, Reda H ^a  

^a TANTA UNIVERSITY   (Egypt)

Author keywords

iNOS; In vivo efficacy; Nitazoxanide; Parasite burden; Trichinella spiralis

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITAZOXANIDE; ANTHELMINTIC AGENT; THIAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHELMINTIC ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EARLY INTERVENTION; EXPERIMENTAL INFECTION; HISTOPATHOLOGY; INFLAMMATORY CELL; LARVAL STAGE; MALE; MUSCLE TISSUE; NONHUMAN; PARASITE IDENTIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMALL INTESTINAL TISSUE; THERAPY DELAY; TREATMENT DURATION; TRICHINELLA SPIRALIS; TRICHINELLOSIS ENTERAL PHASE; TRICHINELLOSIS PARENTERAL PHASE; TRICHINOSIS; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; GERMFREE ANIMAL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LARVA; METABOLISM; MUSCLE; PARASITOLOGY; PATHOLOGY; SMALL INTESTINE; TRICHINELLOSIS;

ANIMALS; ANTHELMINTICS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTESTINE, SMALL; LARVA; MALE; MUSCLES; NITRIC OXIDE SYNTHASE TYPE II; RATS; SPECIFIC PATHOGEN-FREE ORGANISMS; THIAZOLES; TRICHINELLA SPIRALIS; TRICHINELLOSIS;

EID: 84989893187     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2016.08.009     Document Type: Article

References (57)

1. Anderson, V.R., Curran, M.P., Nitazoxanide: a review of its use in the treatment of gastrointestinal infections. Drugs 67 (2007), 1947–1967.
2. Attia, R.A., Mahmoud, A.E., Farrag, H.M., Makboul, R., Mohamed, M.E., Ibraheim, Z., Effect of myrrh and thyme on Trichinella spiralis enteral and parenteral phases with inducible nitric oxide expression in mice. Mem. Inst. Oswaldo Cruz 110 (2015), 1035–1041.
3. Boczon’, K., Wandurska-Nowak, E., Wierzbicki, A., Frydrychowicz, M., Mozer-Lisewska, I., Zeromski, J., mRNA expression and immunohistochemical localization of inducible nitric oxide synthase (NOS-2) in the muscular niche of Trichinella spiralis. Folia Histochem. Cytobiol. 42 (2004), 209–213.
4. Chero, J.C., Saito, M., Bustos, J.A., Blanco, E.M., Gonzalvez, G., Garcia, H.H., Hymenolepis nana infection: symptoms and response to nitazoxanide in field conditions. Trans. R. Soc. Trop. Med. Hyg. 101 (2007), 203–205.
5. Cui, J., Li, L.G., Jiang, P., Liu, R.D., Yang, X., Liu, L.N., Liu, P., Zhang, S.B., Wang, Z.Q., Biochemical and functional characterization of the glutathione S-transferase from Trichinella spiralis. Parasitol. Res. 114 (2015), 2007–2013.
6. Delgado, O.M., Fernandez, G., Silva, S., Ramirez, O., Romero, J., Rodriguez-Morales, A.J., Preliminary evidence of nitazoxanide activity on Toxocara canis in a mouse model. Int. J. Antimicrob. Agents 31 (2008), 182–184.
7. Denham, D.A., Studies with methyridine and Trichinella spiralis. I. Effect upon the intestinal phase in mice. Exp. Parasitol. 17 (1965), 10–14.
8. Derda, M., Boczon, K., Wandurska-Nowak, E., Wojt, W., Changes in the activity of glutathione-S-transferase in muscles and sera from mice infected with Trichinella spiralis after treatment with albendazole and levamisole. Parasitol. Res. 89 (2003), 509–512.
9. Diaz, E., Mondragon, J., Ramirez, E., Bernal, R., Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico. Am. J. Trop. Med. Hyg. 68 (2003), 384–385.
10. Dunn, I.J., Wright, K.A., Cell injury caused by Trichinella spiralis in the mucosal epithelium of B10A mice. J. Parasitol. 71 (1985), 757–766.
11. Fonseca-Salamanca, F., Martinez-Grueiro, M.M., Martınez-Fernandez, A.R., Nematocidal activity of nitazoxanide in laboratory models. Parasitol. Res. 91 (2003), 321–324.
12. Fox, L.M., Saravolatz, L.D., Nitazoxanide: a new thiazolide antiparasitic agent. Clin. Infect. Dis. 40 (2005), 1173–1180.
13. Gagliardo, L.F., McVay, C.S., Appleton, J.A., Molting, ecdysis, and reproduction of Trichinella spiralis are supported in vitro by intestinal epithelial cells. Infect. Immun. 70 (2002), 1853–1859.
14. Garcia, J.J., Bolas, F., Torrado, J.J., Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole. Int. J. Pharm. 250 (2003), 351–358.
15. Garside, P., Grencis, R.K., Mowat, A.M., T lymphocyte dependent enteropathy in murine Trichinella spiralis infection. Parasite Immunol. 14 (1992), 217–225.
16. Gilles, H.M., Hoffman, P.S., Treatment of intestinal parasitic infections: a review of nitazoxanide. Trends Parasitol. 18 (2002), 95–97.
17. Gottstein, B., Pozio, E., Nöckler, K., Epidemiology, diagnosis, treatment, and control of trichinellosis. Clin. Microbiol. Rev. 22 (2009), 127–145.
18. Hemphill, A., Mueller, J., Esposito, M., Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections. Expert Opin. Pharmacother. 7 (2006), 953–964.
19. Hoffman, P.S., Sisson, G., Croxen, M.A., Welch, K., Harman, W.D., Cremades, N., Morash, M.G., Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori and selected anaerobic bacteria and parasites, and Campylobacter jejuni. Antimicrob. Agents Chemother. 51 (2006), 868–876.
20. Hu, Y., Ellis, B.L., Yiu, Y.Y., Miller, M.M., Urban, J.F., Shi, L.Z., Aroian, R.V., An extensive comparison of the effect of the anthelminthic classes on diverse nematodes. PLoS One, 8, 2013, e70702.
21. Issa, R.M., El-Arousy, M.H., Abd EI-Aal, A.A., Albendazole: a study of its effect on experimental Trichinella spiralis infection in rats. Egypt. J. Med. Sci. 19 (1998), 281–290.
22. James, S., Role of nitric oxide in parasitic infections. Microbiol. Rev. 59 (1995), 533–547.
23. Kukhaleva, I.V., Kovalenko, F.P., Shkolyar, N.A., Legonkov, Y.A., Musaev, A.K.H., Bulanova, T.E., Samochatova, E.I., Therapeutic activity of micronized mebendazole in the muscular phase of experimental Trichinella spiralis invasion in albino mice. Med. Parazitol. Parazit. Bolezni 4 (2015), 36–39.
24. Lee, L.Y., Chi-Ming, W., Wang, C.C., Song, J.Y., Liang, Y., Kuo-Hao, H., Hong, L.C., Hwang, T.L., Expression of matrix metalloproteinases MMP-2 andMMP-9 in gastric cancer and their relation to claudin-4 expression. Histol. Histopathol. 23 (2008), 515–521.
25. Li, C.K., Seth, R., Gray, T., Bayston, R., Mahida, Y.R., Wakelin, D., Production of proinflammatory cytokines and inflammatory mediators in human intestinal epithelial cells after invasion by Trichinella spiralis. Infect. Immun. 66 (1998), 2200–2206.
26. Liu, C., Zhang, H., Yin, J., Hu, W., In vivo and in vitro efficacies of mebendazole, mefloquine and nitazoxanide against cyst echinococcosis. Parasitol. Res. 114 (2015), 2213–2222.
27. Liu, R.D., Wang, Z.Q., Wang, L., Long, S.R., Ren, H.J., Cui, J., Analysis of differentially expressed genes of Trichinella spiralis larvae activated by bile and cultured with intestinal epithelial cells using real-time PCR. Parasitol. Res. 112 (2013), 4113–4120.
28. McConnell, E.L., Basit, A.W., Murdan, S., Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in vivo experiments. J. Pharm. Pharmacol. 60 (2008), 63–70.
29. McNeill, E., Crabtree, M.J., Sahgal, N., Patel, J., Chuaiphichai, S., Iqbal, A.J., Hale, A.B., Greaves, D.R., Channon, K.M., Regulation of iNOS function and cellular redox state by macrophage Gch1 reveals specific requirements for tetrahydrobiopterin in NRF2 activation. Free Radic. Biol. Med. 79 (2015), 206–216.
30. Miller, M.J., Thompson, J.H., Zhang, X.J., Sadowska-Krowicka, H., Kakkis, J.L., Munshi, U.K., Sandoval, M., Rossi, J.L., Eloby-Childress, S., Beckman, J.S., Ye, Y.Z., Rodi, C.P., Manning, P.T., Currie, M.G., Clark, D.A., Role of inducible nitric oxide synthase expression and peroxynitrite formation in Guinea pig ileitis. Gastroenterology 190 (1995), 1475–1483.
31. Moilanen, E., Vapaatala, H., Nitric oxide in inflammation and immune response. Ann. Med. 27 (1995), 359–367.
32. Mukaratirwa, S., Gcanga, L., Kamau, J., Efficacy of maslinic acid and fenbendazole on muscle larvae of Trichinella zimbabwensis in laboratory rats. J. Helminthol. 90 (2016), 86–90.
33. Müller, J., Rühle, G., Müller, N., Rossignol, J.F., Hemphill, A., In vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with Caco2 cells. Antimicrob. Agents Chemother. 50 (2006), 162–170.
34. Müller, J., Sidler, D., Nachbur, U., Wastling, J., Brunner, T., Hemphill, A., Thiazolides inhibit growth and induce glutathione-S-transferase P1 (GSTP1)-dependent cell death in human colon cancer cells. Int. J. Cancer 123 (2008), 1797–1806.
35. Müller, J., Rout, S., Leitsch, D., Vaithilingam, J., Hehl, A., Norbert, M.N., Comparative characterisation of two nitroreductases from Giardia lamblia as potential activators of nitro compounds. Int. J. Parasitol. Drugs Drug Resist. 5 (2015), 37–43.
36. Müller, J., Wastling, J., Sanderson, S., Müller, N., Hemphill, A., A novel Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other thiazolides. Antimicrob. Agents Chemother. 51 (2007), 1979–1986.
37. Nyunt, M.M., Plowe, C.V., Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance. Clin. Pharmacol. Ther. 82 (2007), 601–605.
38. Ortiz, J., Lopez Chegne, N., Gargala, G., Favennec, L., Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru. Trans. R. Soc. Trop. Med. Hyg. 96 (2002), 193–196.
39. Petri, W.A., (Chapter 42) Brunton, L.L., Chabner, B.A., Knollmann, B.C., (eds.) Goodman and Gilman's the Pharmacological Basis of Therapeutics, twelfth ed., 2011, McGraw-Hill, New York.
40. Pozio, E., Sacchini, D., Sacchi, L., Tamburrini, A., Alberici, F., Failure of mebendazole in the treatment of humans with Trichinella spiralis infection at the stage of encapsulating larvae. Clin. Infect. Dis. 32 (2001), 638–642.
41. Rao, R.U., Huang, Y., Fischer, K., Fischer, P.U., Weil, G.J., Brugia malayi: effects of nitazoxanide and tizoxanide on adult worms and microfilariae of filarial nematodes. Exp. Parasitol. 121 (2009), 38–45.
42. Ravn, V., Rasmussen, B.B., Hojholt, L., Reproducibility of subjective immunohistochemical estrogen- and progesterone receptor determination in human endometrium. Pathol. Res. Pract. 189 (1993), 1015–1022.
43. Ren, H.J., Cui, J., Wang, Z.Q., Liu, R.D., Normal mouse intestinal epithelial cells as a model for the in vitro invasion of Trichinella spiralis infective larvae. PLoS One, 6, 2011, e27010.
44. Reuter, S., Manfras, B., Merkle, M., Harter, G., Kern, P., In vitro activities of itraconazole, methiazole, and nitazoxanide versus Echinococcus multilocularis larvae. Antimicrob. Agents Chemother. 50 (2006), 2966–2970.
45. Romero Cabello, R., Guerrero, L.R., Munoz Garcia, M.R., Geyne Cruz, A., Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. Trans. R. Soc. Trop. Med. Hyg. 91 (1997), 701–703.
46. Rossignol, J.F., Kabil, S.M., El-Gohary, Y., Younis, A.M., Nitazoxanide in the treatment of amoebiasis. Trans. R. Soc. Trop. Med. Hyg. 101 (2007), 1025–1031.
47. Shalaby, M.A., Moghazy, F.M., Shalaby, H.A., Nasr, S.M., Effect of methanolic extract of Balanites aegyptiaca fruits on enteral and parenteral stages of Trichinella spiralis in rats. Parasitol. Res. 107 (2010), 17–25.
48. Somvanshi, V.S., Ellis, B.L., Hu, Y., Aroian, R.V., Nitazoxanide: nematicidal mode of action and drug combination studies. Mol. Biochem. Parasitol. 193 (2014), 1–8.
49. Stadelmann, B., Scholl, S., Müller, J., Hemphill, A., Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure–activity relationship of thiazolides against Echinococcus multilocularis metacestodes. J. Antimicrob. Chemother. 65 (2010), 512–519.
50. Tritten, L., Silbereisen, A., Keiser, J., Nitazoxanide: In vitro and in vivo drug effects against Trichuris muris and Ancylostoma ceylanicum, alone or in combination. Int. J. Parasitol. Drugs Drug Resist. 2 (2012), 98–105.
51. van den Enden, E., Pharmacotherapy of helminth infection. Expert Opin. Pharmacother. 10 (2009), 435–451.
52. Wandurska-Nowak, E., Wiśniewska, J., Release of nitric oxide during experimental trichinellosis in mice. Parasitol. Res. 88 (2002), 708–711.
53. Wei, X.Q., Charles, I.G., Smith, A., Ure, J., Feng, G.J., Huang, F.P., Xu, D., Muller, W., Moncada, S., Liew, F.Y., Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375 (1995), 408–411.
54. Winning, A., Braslins, P., McCarthy, J.S., Case report: nitazoxanide for treatment of refractory bony hydatid disease. Am. J. Trop. Med. Hyg. 80 (2009), 176–178.
55. Wu, G., Meininger, C.J., Regulation of nitric oxide synthesis by dietary factors. Annu. Rev. Nutr. 22 (2002), 61–86.
56. Yadav, A.K., Temjenmongla, Efficacy of Lasia spinosa leaf extract in treating mice infected with Trichinella spiralis. Parasitol. Res. 110 (2012), 493–498.
57. Yu, Y.R., Liu, X.C., Zhang, J.S., Ji, C.Y., Qi, Y.F., Taurine drinking attenuates the burden of intestinal adult worms and muscle larvae in mice with Trichinella spiralis Infection. Parasitol. Res. 112 (2013), 3457–3463.